Immunovant, Inc. (IMVT)
24.76
+0.92
(+3.86%)
USD |
NASDAQ |
Mar 25, 16:00
24.73
-0.03
(-0.12%)
After-Hours: 04:47
Immunovant Total Liabilities (Quarterly) : 66.26M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Boston Scientific Corp. | 19.20B |
| Plus Therapeutics, Inc. | 12.33M |
| Viridian Therapeutics, Inc. | 177.25M |
| Nutriband, Inc. | 0.8702M |
| Definium Therapeutics, Inc. | 107.77M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.052B |
| Shareholders Equity (Quarterly) | 986.14M |
| Current Ratio | 15.74 |
| Net Debt Paydown Yield | 0.00% |